#307 Marijuana Medicine Approved

Date: Fri, 22 Apr 2005
Subject: #307 Marijuana Medicine Approved


*********************PLEASE COPY AND DISTRIBUTE*************************

DrugSense FOCUS Alert #307 – Friday, 22 April 2005

This past Tuesday the continuing efforts to put medical marijuana into
a regulated commercial market took a huge step forward. Canada became
the first nation to approve a pharmaceutical prescription spray,
Sativex, made from marijuana — a move that could shift the medical
marijuana debate in the U.S.

Sativex is a natural marijuana extract developed by a British company,
GW Pharmaceuticals. It is a liquid that is sprayed into the mouth.
Made from marijuana plants bred for specific levels of various active
components, called cannabinoids, Sativex is similar to marijuana-based
extracts and tinctures which were legally available in the United
States until 1937.

It is expected to be available in Canadian pharmacies within

The approval of Sativex by the Canadian government and the expected
approval in coming months by the government of Great Britain stands as
a direct rebuke of the U.S. government’s insistence that ‘marijuana
has no known or accepted medical value.’

PLEASE CONSIDER writing a Letter to the Editor to one or more of the
newspapers which printed this story.

You can see a continually updating list of these articles


If you choose to write to more than one newspaper, please vary your
message, especially if the newspapers are in the same geographic market.

Our experience has shown that letters submitted Friday through Sunday
have the best chance of being printed for the following week, so
please consider sending your letters soon.

Even if an article about Sativex being approved for use in Canada has
not been printed in newspapers in your area, a short well written
letter about the facts could still be published in those newspapers.
Medical cannabis is an issue of interest to newspapers! Contacts for
sending letters may be found at:


Facts about Sativex may be found at these sources:

Questions and Answers About Sativex – Liquid Medical Marijuana:


GW Pharmaceuticals Frequently Asked Questions:


Thanks for your effort and support.

It’s not what others do it’s what YOU do


Additional suggestions for writing LTEs are at our Media Activism Center:


Or contact MAP Media Activism Facilitator Steve Heath for personal
tips on how to write LTEs that get printed.




Please post a copy of your letter or report your action to the sent
letter list (sentlte@mapinc.org) if you are subscribed, or by
E-mailing a copy directly to heath@mapinc.org if you are not
subscribed. Your letter will then be forwarded to the list so others
can learn from your efforts.

Subscribing to the Sent LTE list (sentlte@mapinc.org) will help you to
review other sent LTEs and perhaps come up with new ideas or
approaches as well as keeping others aware of your important writing

To subscribe to the Sent LTE mailing list see



Prepared by: Stephen Heath, MAP Media Activism Facilitator